Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-048470
Filing Date
2006-03-08
Accepted
2006-03-08 16:58:15
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1354893
2 TERMINATION AGREEMENT, DATED FEBRAURY 24, 2006 dex10461.htm EX-10.46.1 20838
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1435
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2074
5 POWER OF ATTORNEY dex24.htm EX-24 10332
6 302 CERTIFICATION - CHAIRMAN AND CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6890
7 302 CERTIFICATION - CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6795
8 906 CERTIFICATION - CHAIRMAN AND CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3523
9 906 CERTIFICATION - CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3446
  Complete submission text file 0001193125-06-048470.txt   1411622
Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address 100 ENDO BOULEVARD CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Filer) CIK: 0001100962 (see all company filings)

EIN.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15989 | Film No.: 06673699
SIC: 2834 Pharmaceutical Preparations